1. 1308OActivity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx). (23rd October 2018) Authors: Yao, J C; Strosberg, J; Fazio, N; Pavel, M E; Ruszniewski, P; Bergsland, E; Li, D; Tafuto, S; Raj, N; Campana, D; Hijioka, S; Raderer, M; Guimbaud, R; Gajate, P; Pusceddu, S; Reising, A; Degtyarev, E; Mookerjee, B; Aimone, P; Singh, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1316PImpact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study. (23rd October 2018) Authors: Strosberg, J; Hendifar, A; Yao, J C; Kulke, M; O'Dorisio, T; Caplin, M; Baum, R P; Kunz, P; Hobday, T; Wolin, E; Mittra, E S; Oberg, K; Ruszniewski, P; Polack, B; He, B; Barton, D; Santaro, P; Krenning, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1328PUnmet needs in the management of neuroendocrine tumours (NETs): A global survey of patients, patient advocates and healthcare professionals. (23rd October 2018) Authors: Bouvier, C V; Caplin, M; Conroy, S; Davies, P; Dureja, S; Falconi, M; Ferolla, P; Fisher, G A; Goldstein, G; Hicks, R J; Hollander, R; Kolarova, T; Lawrence, B; Leyden, S; Majima, Y; Metz, D; O'Toole, D; Ruszniewski, P; Wiedenmann, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial. (13th August 2019) Authors: Kulke, M H; Ruszniewski, P; Van Cutsem, E; Lombard-Bohas, C; Valle, J W; De Herder, W W; Pavel, M; Degtyarev, E; Brase, J C; Bubuteishvili-Pacaud, L; Voi, M; Salazar, R; Borbath, I; Fazio, N; Smith, D; Capdevila, J; Riechelmann, R P; Yao, J C Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. Issue 4 (August 1996) Authors: Terris, B; Fléjou, J F; Dubois, S; Ruszniewski, P; Scoazec, J Y; Belghiti, J; Potet, F; Bernades, P; Mignon, M; Hénin, D Journal: Journal of clinical pathology Issue: Volume 49:Issue 4(1996) Page Start: M203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Issue 9 (September 1992) Authors: Lehy, T; Cadiot, G; Mignon, M; Ruszniewski, P; Bonfils, S Journal: Gut Issue: Volume 33:Issue 9(1992) Page Start: 1275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Issue 3 (1st September 2002) Authors: Maire, F; Hammel, P; Terris, B; Olschwang, S; O'Toole, D; Sauvanet, A; Palazzo, L; Ponsot, P; Laplane, B; Lévy, P; Ruszniewski, P Journal: Gut Issue: Volume 51:Issue 3(2002) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome. Issue 6 (June 1988) Authors: Ruszniewski, P; Girard, F; Benamouzig, R; Mignon, M; Bonfils, S Journal: Gut Issue: Volume 29:Issue 6(1988) Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. Issue 8 (August 2016) Authors: Cros, J; Hentic, O; Rebours, V; Zappa, M; Gille, N; Theou-Anton, N; Vernerey, D; Maire, F; Lévy, P; Bedossa, P; Paradis, V; Hammel, P; Ruszniewski, P; Couvelard, A Journal: Endocrine-related cancer Issue: Volume 23:Issue 8(2016) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Plexiform neurofibroma mimicking a pancreatic cystic tumour. Issue 11 (13th October 2005) Authors: Handra-Luca, A; Vidaud, D; Vullierme, M-P; Colnot, N; Henin, D; Ruszniewski, P; Bedossa, P; Couvelard, A Journal: Gut Issue: Volume 54:Issue 11(2005) Page Start: 1658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗